Heidelberg

On May 16, I successfully completed my second Master of Science in Medical Biometry/Biostatistics which I did part-time during my Ph.D.. My master's thesis is titled Evaluation of time-to-event data in an adaptive design with stratified randomization for many centers.

My group leader Vincent Heuveline and myself have been interviewed from the Klaus Tschira Foundation about our research project Mathematics in Oncology.

On April 19, I successfully defended my Ph.D. thesis titled Mathematical modeling of Lynch syndrome carcinogenesis. There are no words needed except THANK YOU to all the people who supported me along this way!🎓

I am proud to be part of a new international collaborative initiative, called INDICATE, to unravel the role of the Human Leukocyte Antigen type as a cancer risk modifier in individuals with Lynch syndrome.

Aysel Ahadova and myself, we have written a blog post on the official MathOnco blog to describe the importance of mathematical oncology in studying inherited colorectal cancer. We focus on the most common inherited colorectal cancer syndrome, Lynch syndrome, and give insights into our research projects here in Heidelberg, Germany.

Our collaborative initiative in Heidelberg which started with my PhD in 2017 now became an official 3-year research project funded by the Klaus Tschira Foundation. The aim of the collaborative project Mathematics in Oncology is to understand tumor initiation, evolution, and immunology by means of mathematical modeling and thereby find approaches to potentially prevent hereditary cancer in the future.